Back to Companies
Esperion Therapeutics, Inc.
ESPRNasdaqCIK: 0001434868
Esperion Therapeutics, Inc. (ESPR) shows 26 recent insider filings from 9 insiders, with all of them on the sell side. With $0 in purchases and $474.7K in sales, the recent tape is heavily weighted toward selling (net sales of $474.7K). Koenig Sheldon L. (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $1.6M by Koenig Sheldon L.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$4.2M
Purchases
$0
Sales
$474.7K
Unique Insiders
9
Recent Insider Trades
26 loaded
| Jul 13 | ESPR Esperion Therapeutics, Inc. | CARROLL J MARTIN | Director | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin | Chief Legal Officer | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Shepard Jay | Director | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Harlow John B. Jr. | Chief Commercial Officer | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | THOMPSON JOHN CRAIG | Director | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Hoffman Robert E. | Director | Disposed | $0 |
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Fischer Seth H. Z. | Director | Disposed | $0 |
| Jun 18 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | $34.0K |
| Jun 18 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin | Chief Legal Officer | Sell | $37.3K |
| Jun 18 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Sell | $169.1K |
| Jun 1 | ESPR Esperion Therapeutics, Inc. | CARROLL J MARTIN | Director | Grant | $0 |
| Jun 1 | ESPR Esperion Therapeutics, Inc. | Hoffman Robert E. | Director | Grant | $0 |
| Jun 1 | ESPR Esperion Therapeutics, Inc. | Shepard Jay | Director | Grant | $0 |
| Jun 1 | ESPR Esperion Therapeutics, Inc. | Fischer Seth H. Z. | Director | Grant | $0 |
| Jun 1 | ESPR Esperion Therapeutics, Inc. | THOMPSON JOHN CRAIG | Director | Grant | $0 |
| Mar 16 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Grant | $1.6M |
| Mar 16 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin | Chief Legal Officer | Grant | $656.9K |
| Jan 21 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin | General Counsel | Sell | $4.9K |
| Dec 18 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | $26.9K |
| Dec 18 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO, Director | Sell | $177.2K |
| Dec 18 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin | General Counsel | Sell | $23.9K |
| Dec 8 | ESPR Esperion Therapeutics, Inc. | Harlow John B. Jr. | Chief Commercial Officer | Grant | $1.4M |
| Nov 17 | ESPR Esperion Therapeutics, Inc. | Harlow John B. Jr. | Chief Commercial Officer | Other | $0 |
| Jul 18 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin | General Counsel | Sell | $1.5K |
26 filings